Ion Channels as Marine Drug Targets

Marine Drugs is glad to announce its first Special Issue book on “ion channels” related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue “Ion Channels as Marine...

Full description

Saved in:
Bibliographic Details
Sonstige:
Year of Publication:2020
Language:English
Physical Description:1 electronic resource (134 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545224104498
ctrlnum (CKB)5400000000041935
(oapen)https://directory.doabooks.org/handle/20.500.12854/69436
(EXLCZ)995400000000041935
collection bib_alma
record_format marc
spelling Sabatier, Jean-Marc edt
Ion Channels as Marine Drug Targets
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020
1 electronic resource (134 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
Marine Drugs is glad to announce its first Special Issue book on “ion channels” related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue “Ion Channels as Marine Drug Targets”. Join us to explore the advanced research outcomes in this field: α-Conotoxin RgIA and a potent analog, RgIA4, in treatment of pain; botulinum toxin-chitosan nanoparticles in treatment of atrial fibrillation; 27-amino acid (aa)-long δ-conotoxin TxVIA that modulates mammalian CaV3.x; first venomics study of Conus tulipa venom; review on marine toxins targeting Kv1 channels; review on synthetic approaches to zetekitoxin AB; and review on marine natural products and drug resistance in latent tuberculosis. The second edition of this Special Issue is open for submissions, we look forward to your contribution.
English
Medicine bicssc
conotoxin
Conus tulipa
intraspecific variation
venomics
transcriptomics
proteomics
conantokins
net hunting strategy
nirvana cabal
ion channel modulators
marine anti-TB compounds
PZA
MTB
latent TB
sponges
nicotinic
chemotherapy
paclitaxel
taxane
neuropathic pain
α9α10
saxitoxin
zetekitoxin AB
voltage-gated sodium channel
guanidine alkaloid
bioactives
conotoxins 2
Kv1
marine toxins
modulators
potassium channels
sea anemone toxins
TxVIA
mammalian NaV channel
selective inhibitor
T-type CaV3.2
botulinum toxin A1
chitosan nanoparticles
antiarrhythmics
pharmacological models of arrhythmia
electrically induced arrhythmia
3-03943-797-6
3-03943-798-4
Sabatier, Jean-Marc oth
language English
format eBook
author2 Sabatier, Jean-Marc
author_facet Sabatier, Jean-Marc
author2_variant j m s jms
author2_role Sonstige
title Ion Channels as Marine Drug Targets
spellingShingle Ion Channels as Marine Drug Targets
title_full Ion Channels as Marine Drug Targets
title_fullStr Ion Channels as Marine Drug Targets
title_full_unstemmed Ion Channels as Marine Drug Targets
title_auth Ion Channels as Marine Drug Targets
title_new Ion Channels as Marine Drug Targets
title_sort ion channels as marine drug targets
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2020
physical 1 electronic resource (134 p.)
isbn 3-03943-797-6
3-03943-798-4
illustrated Not Illustrated
work_keys_str_mv AT sabatierjeanmarc ionchannelsasmarinedrugtargets
status_str n
ids_txt_mv (CKB)5400000000041935
(oapen)https://directory.doabooks.org/handle/20.500.12854/69436
(EXLCZ)995400000000041935
carrierType_str_mv cr
is_hierarchy_title Ion Channels as Marine Drug Targets
author2_original_writing_str_mv noLinkedField
_version_ 1787548496084074496
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03150nam-a2200781z--4500</leader><controlfield tag="001">993545224104498</controlfield><controlfield tag="005">20231214133041.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041935</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69436</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041935</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Sabatier, Jean-Marc</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ion Channels as Marine Drug Targets</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (134 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Marine Drugs is glad to announce its first Special Issue book on “ion channels” related research: Under the great stewardship of the Guest Editor, Dr. Jean-Marc Sabatier, four advanced research articles and three comprehensive review papers were collected in the Special Issue “Ion Channels as Marine Drug Targets”. Join us to explore the advanced research outcomes in this field: α-Conotoxin RgIA and a potent analog, RgIA4, in treatment of pain; botulinum toxin-chitosan nanoparticles in treatment of atrial fibrillation; 27-amino acid (aa)-long δ-conotoxin TxVIA that modulates mammalian CaV3.x; first venomics study of Conus tulipa venom; review on marine toxins targeting Kv1 channels; review on synthetic approaches to zetekitoxin AB; and review on marine natural products and drug resistance in latent tuberculosis. The second edition of this Special Issue is open for submissions, we look forward to your contribution.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conotoxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Conus tulipa</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">intraspecific variation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">venomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transcriptomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proteomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conantokins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">net hunting strategy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nirvana cabal</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ion channel modulators</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine anti-TB compounds</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PZA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MTB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">latent TB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sponges</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nicotinic</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">paclitaxel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">taxane</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neuropathic pain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">α9α10</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">saxitoxin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">zetekitoxin AB</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">voltage-gated sodium channel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">guanidine alkaloid</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bioactives</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">conotoxins 2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Kv1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">marine toxins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">modulators</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">potassium channels</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sea anemone toxins</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TxVIA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mammalian NaV channel</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">selective inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T-type CaV3.2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">botulinum toxin A1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chitosan nanoparticles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiarrhythmics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacological models of arrhythmia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">electrically induced arrhythmia</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-797-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-798-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sabatier, Jean-Marc</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:40:46 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337879790004498&amp;Force_direct=true</subfield><subfield code="Z">5337879790004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337879790004498</subfield></datafield></record></collection>